(E)‐3‐(4‐fluorophenyl)‐1‐(thiophen‐2‐yl)prop‐2‐en‐1‐one | 135950-61-7

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: (E)‐3‐(4‐fluorophenyl)‐1‐(thiophen‐2‐yl)prop‐2‐en‐1‐one
• 英文别名: (2E)-3-(4-fluorophenyl)-1-(thiophen-2-yl)prop-2-en-1-one；(E)-3-(4-fluorophenyl)-1-(thiophen-2-yl)prop-2-en-1-one；(E)-3-(p-fluorophenyl)-1-(thiophen-2-yl)prop-2-en-1-one；3-(4-fluoro-phenyl)-1-thiophen-2-yl-propenone；3t-(4-fluoro-phenyl)-1-[2]thienyl-propenone；3t-(4-Fluor-phenyl)-1-[2]thienyl-propenon；(E)-3-(4-fluorophenyl)-1-thiophen-2-ylprop-2-en-1-one
• CAS: 135950-61-7
• 化学式: C₁₃H₉FOS
• mdl: MFCD00853993
• 分子量: 232.278
• InChiKey: TUACRTLXMOTXHL-VMPITWQZSA-N

物化性质

• 熔点：
  123-124 °C(Solv: ethanol (64-17-5))
• 沸点：
  353.6±42.0 °C(Predicted)
• 密度：
  1.265±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  45.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (E)‐3‐(4‐fluorophenyl)‐1‐(thiophen‐2‐yl)prop‐2‐en‐1‐one 在 sodium hydroxide 作用下， 以 乙醇 为溶剂， 反应 13.0h， 生成 4-(benzofuran-2-yl)-2-(5-(4-fluorophenyl)-3-(thiophen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole
  参考文献：
  名称：

  Novel 2-pyrazolin-1-ylthiazoles as Potential Antimicrobial Agents

  摘要：

  DOI：

  10.2174/2212797611306010004
• 作为产物：
  描述：

  2-乙酰基噻吩 、 对氟苯甲醛 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 生成 (E)‐3‐(4‐fluorophenyl)‐1‐(thiophen‐2‐yl)prop‐2‐en‐1‐one
  参考文献：
  名称：

  Design and synthesis of spiro derivatives containing a thiophene ring and evaluation of their Anti-microbial activity

  摘要：

  通过苯丙氨酸和靛红与双极性亲核试剂发生1,3-偶极环加成反应，已成功合成了一系列新型螺吡咯烷。该反应具有高度的位阻和立体选择性。通过元素分析和光谱技术（即红外光谱、1H核磁共振和13C核磁共振）对产物进行了表征。化合物4k的单晶分析和2D-NMR分析证实了螺吡咯烷衍生物的结构。对这些化合物的抗菌活性进行了评估。大多数合成化合物对微生物表现出良好的活性。

  DOI：

  10.13005/ojc/300421

文献信息

• Pyridine anchors for HMG-CoA reductase inhibitors
  申请人：E. R. Squibb & Sons, Inc.

  公开号：US05506219A1

  公开（公告）日：1996-04-09

  Compounds which are useful as inhibitors of cholesterol biosynthesis and thus as hypocholesterolemic agents are provided which have a quinoline or a pyridine anchor attached by means of a linker to a binding domain sidechain, which compounds inhibit the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

  提供了一些有用的化合物，这些化合物可作为胆固醇生物合成抑制剂，因此可作为降胆固醇药物。这些化合物具有喹啉或吡啶锚点，通过连接剂连接到结合域侧链，这些化合物抑制酶3-羟基-3-甲基戊二酰辅酶A还原酶。
• Nematicidal pyrazoles
  申请人：Nihon Bayer Agrochem K.K.

  公开号：US06310049B1

  公开（公告）日：2001-10-30

  Novel pyrazoles of formula (1) wherein R1 represents halogen, C1-6 alkyl, C1-5 haloalkyl, C2-6 alkoxy, C1-4 alkylthio, C2-5 alkenyloxy, C3-5 alkynyloxy, C2-6 (total carbon number) alkoxyalkyl, C2-6 (total carbon number) alkylthioalkyl, C1-5 haloalkoxy, C2-6 (total carbon number) alkoxyalkoxy, hydroxy or optionally substituted phenyl, R2 represents hydrogen, halogen, C1-5 alkyl, C2-6 (total carbon number) alkoxyalkyl, C2-6 (total carbon number) alkylthioalkyl, C2-6 (total carbon number) alkylsulfinylalkyl, C2-6 (total carbon number alkylsulfonylalkyl or C1-5 haloalkyl, R3 represents hydrogen, C1-5 alkyl, —COR4, COOR5, CH(OR6)2 or CH2Si(R7)3, R4 represents C1-10 alkyl, C1-6 haloalkyl, C2-6 alkenyl, optionally substituted C3-6 cycloalkyl, C2-6 (total carbon number) alkoxyalkyl, C2-6 (total carbon number alkylthioalkyl, optionally substituted phenyl, C1-6 haloalkyl, alkylamino, di-(C1-6 alkyl)amino or optionally substituted phenylamino, R5 represents C1-7 alkyl, R6 and R7 represent C1-6 alkyl, and n is 1, 2 or 3, and when n is 2 or 3, the corresponding number (n) of R1 radicals may be the same or different, processes for preparing these compounds and their use as nematicides and anthelmintics.

  式（1）中的新型吡唑化合物，其中R1代表卤素、C1-6烷基、C1-5卤代烷基、C2-6烷氧基、C1-4烷基硫基、C2-5烯基氧基、C3-5炔基氧基、C2-6（总碳数）烷氧基烷基、C2-6（总碳数）烷基硫基烷基、C1-5卤代烷氧基、C2-6（总碳数）烷氧基烷氧基、羟基或可选择地取代的苯基；R2代表氢、卤素、C1-5烷基、C2-6（总碳数）烷氧基烷基、C2-6（总碳数）烷基硫基烷基、C2-6（总碳数）烷基磺酰基烷基、C2-6（总碳数）烷基磺基烷基或C1-5卤代烷基；R3代表氢、C1-5烷基、—COR4、COOR5、CH(OR6)2或CH2Si(R7)3；R4代表C1-10烷基、C1-6卤代烷基、C2-6烯基、可选择地取代的C3-6环烷基、C2-6（总碳数）烷氧基烷基、C2-6（总碳数）烷基硫基烷基、可选择地取代的苯基、C1-6卤代烷基、烷基氨基、二（C1-6烷基）氨基或可选择地取代的苯基氨基；R5代表C1-7烷基；R6和R7代表C1-6烷基；n为1、2或3，当n为2或3时，相应数量（n）的R1基团可以相同或不同，以及制备这些化合物的方法以及它们作为线虫杀和驱虫剂的用途。
• Phosphorus-containing inhibitors of HMG-CoA reductase. 2. Synthesis and biological activities of a series of substituted pyridines containing a hydroxyphosphinyl moiety
  作者：Jeffrey A. Robl、Laurelee A. Duncan、Jelka Pluscec、Donald S. Karanewsky、Eric M. Gordon、Carl P. Ciosek、Lois C. Rich、Viviane C. Dehmel、Dorothy A. Slusarchyk

  DOI：10.1021/jm00113a019

  日期：1991.9

  A series of 2,3,4,(5),6-substituted pyridines containing a hydroxyphosphinyl functionally have been prepared and were evaluated for their ability to inhibit the enzyme HMG-CoA reductase. Systematic substitution of both R1-R4 and X-Y led to compounds of type 3-6 with in vitro potency greater than that of mevinolin (Na salt).

  已经制备了一系列的2,3,4，（5），6-取代的功能上含有羟基膦酰基的吡啶，并对其抑制酶HMG-CoA还原酶的能力进行了评估。R1-R4和XY的系统取代产生了3-6型化合物，其体外效能大于mevinolin（Na盐）。
• Chemoselective generation of acyl phosphates, acylium ion equivalents, from carboxylic acids and an organophosphate ester in the presence of a Brønsted acid
  作者：Akinari Sumita、Yuko Otani、Tomohiko Ohwada

  DOI：10.1039/c6cc09618b

  日期：——

  Reactions of an organophosphate ester with carboxylic acids proceeded smoothly and chemoselectively in the presence of a Bronsted acid, affording acyl phosphate intermediates, leading to formation of various functional aromatic ketones.

  有机磷酸酯与羧酸的反应在布朗斯台德酸的存在下平稳且化学选择性地进行，从而提供了酰基磷酸酯中间体，从而导致形成各种功能性芳族酮。
• NEW HISTONE DEACETYLASE INHIBITORS BASED SIMULTANEOUSLY ON TRISUBSTITUTED 1H-PYRROLES AND AROMATIC AND HETEROAROMATIC SPACERS
  申请人：Cossío Mora Fernando Pedro

  公开号：US20120196885A1

  公开（公告）日：2012-08-02

  The present invention refers to compounds derived from trisubstituted 1H-pyrrole rings and aromatic rings, which have the following formula (I): wherein: R 1 and R 2 represent, independently, an optionally substituted C 6 -C 10 aryl radical or an optionally substituted heteroaryl radical; A and M represent, independently, a methylene group or a single bond, in which case the adjacent aromatic ring would be attached directly to the amide group; the Y═Z group represents together and indistinctly an oxygen atom, a sulfur atom, a cis-vinylidene group, an imino group, or a methine group with a sp 2 -hybridized carbon atom; X represents indistinctly a methine group, a cis-vinylidene group or a nitrogen atom; and W represents a hydroxyl group, an optionally substituted C 1 -C 6 alkyl group, an optionally substituted heteroaryl group or an optionally substituted C 6 -C 10 aryl group; or a salt, solvate or prodrug thereof, as well as to the process for their preparation and the use thereof for the treatment of cancer.

  本发明涉及从三取代的1H-吡咯环和芳香环衍生的化合物，其具有以下公式（I）： 其中： R1和R2分别表示一个可选择取代的C6-C10芳基基团或一个可选择取代的杂环基团； A和M分别表示一个亚甲基基团或一个单键，此时相邻的芳香环将直接连接到酰胺基团； Y═Z基团一起表示一个氧原子、硫原子、顺式-乙烯基团、亚胺基团或具有sp2杂化碳原子的甲基基团； X不明确地表示一个甲基基团、顺式-乙烯基团或一个氮原子； W表示一个羟基、一个可选择取代的C1-C6烷基基团、一个可选择取代的杂环基团或一个可选择取代的C6-C10芳基基团； 或其盐、溶剂合物或前药，以及其制备方法和用于治疗癌症的用途。